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Abstract
Background: A growing body of research assesses population need for substance use services. However, the
extent to which survey research incorporates expert versus consumer perspectives on service need is unknown. We
conducted a large, international review to (1) describe extant research on population need for substance use
services, and the extent to which it incorporates expert and consumer perspectives on service need, (2) critically
assess methodological and measurement approaches used to study consumer-defined need, and (3) examine the
potential for existing research that prioritizes consumer perspectives to inform substance use service system
planning.
Methods: Systematic searches of seven databases identified 1930 peer-reviewed articles addressing population
need for substance use services between January 1980 and May 2015. Empirical studies (n = 1887) were categorized
according to source(s) of data used to derive population estimates of service need (administrative records,
biological samples, qualitative data, and/or quantitative surveys). Quantitative survey studies (n = 1594) were
categorized as to whether service need was assessed from an expert and/or consumer perspective; studies
employing consumer-defined need measures (n = 217) received further in-depth quantitative coding to describe
study designs and measurement strategies.
Results: Almost all survey studies (96%; n = 1534) used diagnostically-oriented measures derived from an expert
perspective to assess service need. Of the small number (14%, n = 217) of survey studies that assessed consumer’s
perspectives, most (77%) measured perceived need for generic services (i.e. ‘treatment’), with fewer (42%)
examining self-assessed barriers to service use, or informal help-seeking from family and friends (10%).
Unstandardized measures were commonly used, and very little research was longitudinal or tested hypotheses.
Only one study used a consumer-defined need measure to estimate required service system capacity.
Conclusions: Rhetorical calls for including consumer perspectives in substance use service system planning are
belied by the empirical literature, which is dominated by expert-driven approaches to measuring population need.
Studies addressing consumer-defined need for substance use services are conceptually underdeveloped, and
exhibit methodological and measurement weaknesses. Further scholarship is needed to integrate multidisciplinary
perspectives in this literature, and fully realize the promise of incorporating consumer perspectives into substance
use service system planning.
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Background
Over the past four decades, significant progress has been
made in the treatment of substance use disorders [1]. A
large international literature shows that ‘treatment
works,’ with evidence that a variety of treatment inter-
ventions and supports produce significant reductions in
substance misuse and improve the health and social
functioning of people seeking help for problems with
alcohol and other drugs [2–5]. Despite this progress,
substance use disorders continue to affect almost 150
million people worldwide [6] and many never receive
care for these conditions. Misuse of alcohol and other
drugs is a growing cause of noncommunicable disease
burden, accounting for 2.9 million deaths and over 120
million disability-adjusted life-years (DALYs) in 2010
alone [7, 8]. Alleviating suffering by closing this treat-
ment gap has been declared a global mental health
priority [9].
In the United States and elsewhere, concerted efforts
to scale up population access to substance use services
and supports began in the 1980s [10, 11]. These efforts
were accompanied by studies attempting to estimate
population need for care in relation to existing service
coverage. This reflected a shift away from research charac-
terizing the demographic and clinical correlates of
treatment-seekers, toward community-based studies of
need for services in both general and special populations,
regardless of whether general health care or specialty
addiction treatment was actually sought or received [12].
Conceptualizing population need for substance use services
Initial approaches used indirect estimation techniques
designed to quantify need for services in relation to the
prevalence of substance use and misuse in the general
population, using a variety of statistical models applied
to administrative datasets (e.g., retail alcohol sales, mor-
tality data, HIV testing databases) [13–16]. However,
administrative datasets have limited capacity to inform
service system planning because they typically do not
differentiate between subpopulations that might benefit
from different types of services in relation to problem
severity, e.g., substance misusers versus those meeting
diagnostic criteria for substance use disorders; or people
who do and do not exhibit comorbid substance use and
mental disorders. These limitations hinder efforts to esti-
mate how many people in the general population could
benefit from accessing the variety of treatment interven-
tions and supports for substance misuse typically offered
by general healthcare and speciality service systems (e.g.,
brief interventions, outpatient care, speciality residential
treatment) [14].
More recently, research turned to direct estimation
methods using community-based population surveys.
These approaches attempt to quantify population need
for services in relation to prevalence of substance use
disorders, as assessed by structured diagnostic instruments
(e.g., the Composite International Diagnostic Interview
[CIDI]) [12, 17]. Two American studies, the Epidemio-
logical Catchment Area Program (ECA; 1980–1985) [18]
and the first iteration of the National Co-Morbidity Study
(NCS; 1990–1992) [19] were early examples of this ap-
proach. These seminal studies clearly documented that
most people meeting diagnostic criteria for substance use
disorders do not access health services. Past year general
health care and specialty treatment rates in the ECA were
23.6% for respondents meeting diagnostic criteria for any
substance use disorder [18], and varied between 11.6%
(alcohol abuse) to 46.8% (drug dependence) in the NCS [20].
Other countries have since implemented large population-
based mental health surveys with similar results [17, 21].
Expert versus consumer perspectives on population need
for services
These consistent findings of large treatment gaps for
substance use and other mental health problems led to
questions about the validity of diagnostic systems used
in population-based studies of service need. Some specu-
lated that disorder prevalence estimates were inflated,
and not a true reflection of actual need for care in the
population [11, 12]. Several changes were subsequently
made to the fourth edition of the Diagnostic and
Statistical Manual (DSM-IV) and the CIDI in order to
provide information to complement diagnoses, including
clinical significance, impairment, and disability [22–24].
Although these changes yielded more conservative preva-
lence estimates [24], they continued to prioritize an expert
perspective on population need for services. This priority
has been called into question, however, in light of growing
evidence that diagnostically-assessed need for care is only
modestly predictive of actual service use [11, 24–27]. For
example, Demyttenaere and colleagues [25] report that
across seven high-income countries, 36 to 50% of respon-
dents meeting diagnostic criteria for severe substance use
and mental disorders had no past year service use; and
that most individuals receiving care were ‘subthreshold’
cases that exhibited low-severity problems, or failed to
meet diagnostic criteria [11, 27].
From a broader health system perspective, deinstitu-
tionalization of mental health and substance use services,
cost-cutting and increasing reliance on community-based
mental health supports, and the growth of countercultural
anti-psychiatry and mental health survivor movements in
the later half of the 20th century precipitated a shift in
thinking regarding the role of patients in the mental
health system [28]. Ex-patient voices gained prominence
in the wake of failed system reforms, and began challen-
ging medical authority including involuntary confinement
and aggressive treatment approaches. New service delivery
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models emerged that increasingly conceptualized patients
as active participants in mental health care, with insight
on their own conditions, and the ability to make treatment
decisions based on their own sense of well-being [28].
These models imply that assessing population need for
care for substance misuse is a socially negotiated process
that is at least partially determined by consumers’ percep-
tions of need for care [29–31]. The importance of
consumer-defined need for services echoes Andersen’s
[32] influential model of healthcare utilization, wherein
predisposing and enabling factors affect individual percep-
tions of healthcare needs, and these perceptions are theo-
rized to be a proximal determinant of service use. From
this perspective, assessing consumers’ subjective views on
service need is at least as important as determining diag-
nostic prevalence rates for researchers attempting to
quantify population need for services with an eye toward
service system planning [29, 30]. Two related concepts
emphasizing a consumer perspective: self-assessed barriers
to care [33], and help - seeking from friends or family
members (potentially in lieu of formal service use) [34],
have also been examined in this regard.
Emerging research incorporating consumer perspectives
on service need demonstrates that only about 10–30% of
individuals who meet objective diagnostic criteria for
substance use disorders actually perceive a need for care
[35–38], and that perceiving a need for care is strongly as-
sociated with service use [39]. Individuals who do perceive
a need for services, but do not have this care need met, re-
port high levels of disability and distress [40], which tend
to improve once care needs are met [36]. However, 5–21%
of individuals who access services, nevertheless still report
service needs have not been met [35, 36, 40–42]. Research
on consumer-defined need for services also demonstrates
that motivational or attitudinal barriers–such as a desire
to self-manage one’s own symptoms–appear to be more
common than cost or other structural barriers, as reasons
for having unmet care needs [33, 43, 44]. Collectively, the
above findings suggest that expert-defined measures of
population need (i.e. prevalence of alcohol and other drug
misuse, prevalence of substance use disorders, and/or
service utilization rates) are necessary, but may be insuffi-
cient for generating robust estimates of population need
for services.
Research aims
Direct estimation using surveys has become a recom-
mended approach for making inferences about popula-
tion need for substance use services [27]. Several studies
estimate population need for substance use services
using an expert perspective, and use the results to esti-
mate required service system capacity [45–47]. However,
many have called for complementing diagnostically-
oriented approaches to direct estimation with consumer-
defined need measures [27, 45], since they have the po-
tential to provide a more complete assessment of popu-
lation need for services [48–50].
Unfortunately, to our knowledge, no previous reviews
have systematically mapped the large interdisciplinary
literature on approaches to assessing population need
for substance use services, or assessed the extent to
which consumer perspectives have been incorporated.
Moreover, no research has taken stock of the variety of
measurement approaches used to assess consumer-
defined need, nor the utility of these studies for inform-
ing service system planning. To address this gap, we
conducted a systematic scoping review to critically
analyze the literature describing population need for
substance use services. Scoping reviews “aim to map
rapidly the key concepts underpinning a research area,
and the main sources and types of evidence available”
([51], p. 194). They are particularly appropriate when, as
here, an area of literature is interdisciplinary, conceptu-
ally complex, and has not been systematically reviewed
before. Our specific aims were to (1) describe extant re-
search on population need for substance use services,
and the extent to which it incorporates expert and con-
sumer perspectives on service need, (2) critically assess
the methodological and measurement approaches used
to study consumer-defined need for substance use ser-
vices, and (3) examine the potential for existing research
that prioritizes consumer perspectives to inform sub-
stance use service system planning.
Methods
Our study protocol was adapted from Arksey and
O’Malley’s [52] scoping review framework. Although our
review was not intended to assess study quality or
synthesize research evidence, the PRISMA reporting guide-
lines for systematic reviews [53] informed the reporting of
our results.
Search strategy
LS (a professional health sciences research librarian) led
the development of our systematic search strategy and
executed the final search. We conducted multiple test
searches using an a priori list of keywords and subject
headings to develop and refine database-specific con-
trolled vocabularies (Additional file 1) designed to iden-
tify relevant studies using a broadly inclusive approach
based on two central concepts: ‘substance use services’
and ‘population need assessment.’ We searched seven
databases including Medline®, Embase®, PsycInfo, EBSCO
CINAHL Plus®, Scopus®, Web of Science® Core Collection,
and Evidence-based Medicine Reviews® to maximize the
breadth of our results. The scope was limited to English
language, peer-reviewed journal articles and book chapters
[not editorials/commentaries, conference abstracts, letters,
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or dissertations] published between 1980 and May 28,
2015 and available via the University of Alberta hold-
ings. Our search identified 23,005 records. A total of
8736 duplicates were removed, leaving a sample of
14,269 unique records.
Screening
All titles and abstracts were screened for relevance.
Comprehensive inclusion and exclusion criteria are out-
lined in Table 1. EH, KK, and BT screened the records.
To ensure consistency in the screening process, all raters
assessed and monitored inter-rater agreement on triag-
ing decisions using Light’s Kappa coefficient [54, 55]. In-
stances of disagreement were discussed with JJ and
TCW and the inclusion and exclusion criteria were re-
fined and clarified, as necessary. Raters co-screened 10
consecutive batches of 50 records until acceptable inter-
rater agreement on article screening was reached (Light’s
Kappa = 0.8). Screening then proceeded independently
among the raters, although eight additional random
batches of 50 were co-screened periodically to verify that
acceptable agreement was maintained throughout the
screening stage (Light’s kappa = 0.8 or greater). The title
and abstract screening stage identified 2138 potentially
relevant records. The full text of each record was then
reviewed and relevant data extracted based on a stand-
ard coding framework. During this process, an additional
208 articles were determined to be ineligible or met ex-
clusion criteria. Figure 1 reports our systematic search
strategy flow diagram in accordance with PRISMA
guidelines [53]. The remaining 1930 articles are included
within the scope of this review.
Data extraction
We developed a coding framework for included articles
based on knowledge of the literature and preliminary
analysis of included articles (see Additional file 2). EH
coded all articles for: single or cross-national study;
country; country type (high, middle or low income); glo-
bal region; and whether or not empirical data were re-
ported. All empirical articles (n = 1887) were then coded
according to the type (s) of data used to derive population
estimates of service need (administrative, biological, quali-
tative, or quantitative survey). All empirical studies using
quantitative survey data (n = 1594) were classified accord-
ing to whether they used one or more expert-defined
measures (i.e., substance use prevalence, substance use
disorder prevalence, service utilization rates) and/or one
or more consumer-defined measures (i.e., perceived need
for services, self-assessed barriers to service use, and/or
self-reported help-seeking from family or friends).
In-depth coding was conducted on all studies containing
one or more measures of consumer-defined need for ser-
vices (n = 217; see Additional file 3, which contains a
complete list of articles presenting one or more measures
of consumer-defined need). These articles were coded for:
study design; target population; participant characteristics;
measurement (single, multi-item and standardized mea-
sures) and analytical approaches (descriptive vs. hypothesis-
driven). We also coded whether or not each study esti-
mated required service system capacity using one or more
measures of consumer-perceived need for services. All
articles containing consumer-defined measures were double
coded by KK and BT. Disagreements were discussed with
EH and corrected as appropriate.
Results
Our scoping review identified 1930 articles. Figure 2
describes these articles by data source and publication year.
Overall, 1887 articles reported empirical data: 83%
(n = 1594) estimated population need for services
using quantitative survey data, 20% (n = 380) used
administrative data, 6% (n = 116) used qualitative data,
and 3% (n = 62) used biological samples (e.g., urinaly-
sis). These percentages do not sum to one hundred,
as a subset of these articles (13%; n = 251) used more
than one type of data.
Almost all population survey studies (95%; n = 1512)
reported data collected from within one country only.
Amongst these studies, 88% (n = 1335) were conducted in
high-income countries, with over half (56%; n = 853) in
the United States alone. The vast majority (84%; n = 1334)
of population survey studies were published between 2000
and 2015, with 38% (n = 611) published since the start of
Table 1 Scoping review inclusion and exclusion criteria
Articles were included if they:
1. Measured population need for substance use services using
expert-defined (use prevalence, diagnostic prevalence, service utilization)
and/or consumer-defined measures (perceived need, barriers to care, or
help-seeking from family and friends); and
2. Recruited samples from community settings; and/or
3. Outlined one or more methods for assessing population need for
substance use services or estimating required substance use service
system capacity; and/or
4. Reviewed literature on methodological or conceptual issues in
assessing population need for substance use services.
Articles were excluded if they:
1. Described need for substance use services exclusively amongst
treatment-seeking or clinical samples; or
2. Described need for services not intended to mitigate substance use
disorders/problematic use directly (e.g. Hepatitis C treatment, HIV
prevention programs, dental care); or
3. Described service needs among populations experiencing mental
disorders only (i.e. excluded substance use disorders); or
4. Were effectiveness or cost-effectiveness studies; or
5. Narratively summarized empirical findings of previous research on
population need for substance use services.
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Fig. 1 Systematic search strategy flow diagram. Adapted from PRISMA 2009 Flow Chart (The PRISMA Group, 2009). 208 full text articles excluded
for the following reasons: assessed treatment-seekers only (n = 56); focus on general health status or other health problem (e.g., need for HIV care)
(n = 28); mental health only, excludes substance use (n = 3); non-empirical, not relevant to assessment of need (n = 2); did not assess population
need directly (e.g., survey of administrators' opinions on need) (n = 6); intervention study (n = 9); non-English (n = 14); not a journal article (e.g.,
commentary) (n = 17); full text could not be retrieved (n = 73)
Fig. 2 Frequency of studies addressing population need for substance use services by data type, and year (n = 1930). Thirty-nine studies published
between January 1 and May 28 2015 were excluded from this figure due to incomplete data for 2015
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2010. Figure 3 describes the extent to which survey studies
(n = 1594) used expert and/or consumer-defined ap-
proaches to estimate population need for substance use
services, over time. In total, 96% (n = 1534) of survey
research articles reported data derived from one or more
expert-defined measures, and 84% (n = 1333) reported
expert-defined estimates exclusively. In contrast, only 14%
(n = 217) of all survey research articles reported data
derived from one or more consumer-defined measures of
need for service. The majority (93%; n = 201) of the
articles reporting consumer-defined need estimates also
included expert-defined need estimates. Only 16 articles
(7%) reported consumer-defined estimates exclusively. A
small number (3%; n = 44) of population survey studies
met study inclusion criteria, but did not use either expert
or consumer-defined need measures. Examples of these
articles include studies that described demographic (or
other characteristics) of community-based substance users
[56], but not service need.
Amongst expert-defined need studies, 63% (n = 965)
reported diagnostic prevalence, 52% (n = 794) reported
substance use prevalence, and 51% (n = 776) reported
rates of service use. Figure 4 illustrates how expert-
defined need has been conceptualized in the literature
on population need for substance use services. Almost one
quarter of studies (23%; n = 346) report both diagnostic
prevalence and service use estimates. However, studies
reporting only estimates of substance use prevalence
(20%; n = 304) are also common. Only 10.7% (n = 165)
of studies report data derived from all three expert-
defined need measures.
Consumer-defined approaches to measuring population
need for substance use services
Target populations
In-depth coding of consumer-defined need studies indi-
cated that 36% (n = 77) recruited ‘user-only’ samples,
where participants were required to report substance
use to be eligible for the study. Most of these studies
recruited unspecified drug users (31%; n = 24), injection
drug users (25%; n = 19), or stimulant users (22%; n = 17).
Studies conducted with representative samples of general
adult populations also comprised a significant proportion
(35%; n = 76) of research on consumer-defined need for
substance use services. Of these, 83% (n = 63) reported
findings from the US, 8% (n = 6) from Canada, 3% (n = 2)
from Australia, with the remaining proportion comprised
of individual studies from New Zealand, the United
Kingdom, Mexico, China, and South Korea. Additionally,
30% (n = 64) of consumer-defined need studies were
conducted amongst members of special populations. The
most common special populations studied were adults and
youth involved in criminal justice systems (34%; n = 24) and
people experiencing homelessness (25%; n = 16). Sample
sizes ranged between 18 and 336,003. In terms of sample
demographics, most (86%; n = 185) consumer-defined need
studies included both male and female participants. The
mean age of participants ranged from 13 to 75 (amongst
the 108 studies where age was reported). Finally, with
regards to study design, the majority of consumer-defined
need studies adopted a cross-sectional (86%; n = 187) rather
than longitudinal design, and produced descriptive analyses
(79%; n = 172), rather than testing specific hypotheses.
Fig. 3 Frequency of survey research studies containing one or more measures of expert-defined need, consumer-defined need, or both expert
and consumer-defined need, by publication year (n = 1594). Expert-defined need: reporting one or more of: prevalence of substance use, prevalence
of substance use disorders (using some expert diagnostic criteria), and/or substance use service utilization rates. Note that ‘user-only’ studies (i.e.,
studies where eligibility criteria included substance use) were only coded as reporting a substance use prevalence estimate when survey data were
combined with administrative data to estimate population prevalence of use. Consumer-defined need: reporting one or more of: perceived need for
substance use services, self-assessed barriers to accessing substance use services, and/or informal help-seeking from family or friends. 36 studies published
between January 1 and May 28 2015 were excluded from this figure due to incomplete data for 2015
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Measurement approaches
Most studies (77%; n = 167) assessing consumer perspec-
tives reported perceived need estimates, with far fewer
measuring self-assessed barriers to service use (42%; n =
92), or help - seeking from family or friends (10%; n = 21).
Overall, 72% (n = 156) of these studies included only one
consumer-defined need measure and only two studies
(1%) examined all three measures together. Figure 5
illustrates the variety of ways consumer-defined need for
care was assessed.
A variety of single, multiple item, and standardized
measures were used to estimate consumer-defined need
for services. The majority of studies measuring perceived
need (68%; n = 113), and studies measuring help - seeking
(71%; n = 15) assessed these constructs using single item
measures. Just over half (51%; n = 92) of studies measuring
self-assessed barriers to service use adopted multiple-item
measures (measurement details were not specified in 19%
(n = 14) of these studies). Table 2 illustrates the diversity
of single and multiple item measures identified.
Consumer-defined need measures tended to define
substance use services using a variety of different terms
and phrases. For example, amongst studies assessing
perceived need for substance use services, 84% (n = 140)
Fig. 4 Percent of expert-defined service need studies using specific combinations of measures (n = 1534). Use refers to substance use prevalence,
defined as an estimate of the population prevalence of one or more types of substance use. Note that ‘user-only’ studies (i.e., studies where
eligibility criteria included substance use) were only coded as reporting a substance use prevalence estimate when survey data were combined
with administrative data to estimate population prevalence of use. Diagnostic refers to diagnostic prevalence defined as meeting criteria for one
or more substance use disorders or problematic patterns of substance use. Service use is defined as reporting use of one or more substance use
services (general health, social, or specialty substance use and mental health services
Fig. 5 Percent of consumer-defined service need studies using specific combinations of consumer-defined need measures (n = 217). Perceived
need defined as an individuals’ judgments about whether they require substance use services. Self-assessed barriers defined as an individual’s
judgment regarding factors that impede substance use service utilization. Help-seeking defined as self-reporting seeking help from family or
friends for substance use problems
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of measures referred to generic ‘treatment’ only, whereas
the remaining 26% (n = 27) of studies asked about need
for one or more specific service types (e.g. counselling,
pharmacotherapy, syringe exchange). Very few survey
research articles in our review employed standardized
instruments to measure consumer-defined service need.
For example, a standardized instrument was used in only
7% (n = 12) of articles measuring perceived need. Table 3
provides a complete list of all standardized consumer-
defined need measures uncovered in our review.
As outlined at the start of this review, measuring
consumer-defined need for services is an important
endeavor for improving understanding of the substance
use disorder treatment gap, and estimates of perceived
need, in particular, have the potential to enhance
substance use service system planning. We examined
the extent to which consumer-defined need studies
have incorporated data on perceived need into esti-
mates of required system capacity to meet population
need for substance use services. We identified only
one study (n = 1; 0.1%) where perceived need
estimates were used to calculate required service
system capacity. The study was published in 1991
[57] and used telephone survey data to estimate the
number of residential substance use treatment spaces
needed to meet existing levels of perceived need in
Rhode Island.
Given the lack of required system capacity estimates in
the perceived need literature, we also considered the extent
Table 2 Examples of measures used to assess consumer-defined need for substance use services (n = 217)
Single item measures (n = 113)
Perceived need “Do you feel you could use treatment for drug or alcohol use?” [67]
“During the past 12 months, was there ever a time when you felt that you needed help for your emotions, mental health,
or use of alcohol or drugs, but you didn’t receive it?” [40]
Participants were read the following statement: “I now need to get into a drug abuse treatment program.” They were
asked to answer along on a 5 point scale ranging from “strongly disagree” to “strongly agree.” [68]
Self-assessed barriers to service
use
“Have you ever thought you should seek help for drinking, but you did not go?” Those answering yes were queried about the
reasons for not seeking treatment. Answers were grouped into financial, structural, attitudinal and other categories [69].
For all persons who reported having difficulty accessing needles, the following question was then asked: “If yes or
sometimes, why do you find it hard to get new [unused] rigs?” The interviewer did not read out a list of possible
explanations, but had a list of nine possible responses as well as space to note answers that did not fit with one of
the nine categories [70].
Help-seeking from family and/or
friends
“On the last occasion, how did you try to change your drug use?” (response categories: by myself; with family/friends;
home detoxification; residential detoxification; methadone; doctor; counsellor; Alcoholics Anonymous) [71]
Participants were asked whether they had used a range of smoking-cessation supports and aids in the last year (family
and friends were one source queried) [72]
Multiple item measures (n = 52)
Perceived need Participants were asked three items with five-point response scales ranging from strongly disagree to strongly agree: (I)
“In terms of the things I need right now, getting into drug abuse treatment is at the top of the list”; (2) “I now need to get into
drug abuse treatment for drug addiction”; and (3) “Because of my drug use, I now need drug abuse treatment.” The sum of
the scores on these items comprised a composite measure of the perceived need for treatment. Scores could range
from 3 to 15 [73].
“Did you think you needed help for alcohol or drug problems?” Those with a perceived need were asked, “Were there
any times during the past 12 months when you got less treatment for emotional, mental health, alcohol, or drug
problems than you needed, or had difficulties or delays in getting care?” [74]
Self-assessed barriers to service
use
Administered checklist of 36 commonly cited reasons for not seeking treatment for alcohol and drug dependence.
Items pertain to areas like feelings, coping with stress (family, financial and personal), perceived useful effects of
drugs, cost of treatment, perceived effectiveness, treatment related fears and social reasons. The answers were
recorded as Yes/No [75].
“Veterans may face obstacles getting or using mental health services for a number of reasons. Please rate how much you
agree or disagree with each statement as it applies to you.” 17 statements related to treatment effectiveness (e.g., “I
don’t think treatment will help me”), stigma (e.g., “I would be seen as weak by others”), and external barriers (“It’s hard
getting time off work for treatment”) were listed. Responses ranked on a 4-point scale: 1, strongly disagree; 2, somewhat
disagree; 3, somewhat agree; and 4, strongly agree [76].
Help-seeking from family and/
or friends
Participants were asked to rank the perceived helpfulness of 34 interventions and whether they were used in the
previous two years. “Close friend” and “close family” were two interventions listed [34].
Participants were asked whether they had sought help from family and/or friends to reduce/cease methamphetamine
use in the past 30 days. A second measure asked about help from family and/or friends in the past 12 months [77].
Perceived need defined as an individual’s judgments about whether they require substance use services. Self-assessed barriers defined as an individual’s judgment
regarding factors that impede substance use service utilization. Help-seeking defined as self-reporting seeking help from family or friends for substance use problems.
Note that two studies which reported perceived need estimates did not specify whether a single or multi-item measure was used
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to which data reported in these articles could hypothetically
be used to inform system planning. To do this, we
calculated how many articles contained, at minimum, an
estimate of substance use disorder prevalence, service
utilization, and perceived need for a given sample or
population. We selected these variables because they are
the most basic measures required to incorporate perceived
need into estimates of required service system capacity
[49]. In total, 63% (n = 106) of all perceived need articles
contained all three measures, and could potentially be used
to inform substance use service planning. Half of these arti-
cles (n = 54) were derived from general population surveys.
Discussion
This scoping review assessed the extent to which expert
and consumer perspectives were incorporated into
research on population need for substance use services.
We were particularly interested in the extent to which
consumer perspectives were represented in survey research
measuring population need. Because of recent interest in
consumer perspectives, due to efforts to improve direct
estimation methods that quantify population need for
services, [30] we also critically assessed the methodological
and measurement approaches used to study consumer-
defined need for substance use services and their potential
for informing substance use service system planning.
Survey research on population need for substance use
services is growing exponentially, with over 600 studies
conducted since 2010 alone. However, the imperative to
study consumer perspectives–implied both by recogni-
tion of the limitations of using diagnostic prevalence to
predict service use, and Andersen’s [32] influential
model of health services utilization—is belied by the
overwhelming emphasis on expert-defined measures
designed to quantify need for services in the extant
literature. Our review identified relatively few survey
research studies assessing population need for substance
use services, which incorporated any measure of consumer-
defined need. This finding is puzzling, given recognition of
the importance of individual perceptions on health in other
areas of epidemiology (e.g., the concept of ‘lay epidemi-
ology’; [58, 59]) and social sciences research [60].
Overemphasis on expert conceptions undoubtedly re-
flects broader challenges of incorporating consumer per-
spectives into mental health decision-making. Traditionally,
psychiatry and other mental health disciplines have granted
consumers little-to-no control over mental health services
and individual treatment plans [61]. Moreover, those
disagreeing with a diagnosis or prescribed treatment were
often labeled as in denial, lacking insight, or irrational
[62]. Such efforts to defend professional boundaries and
legitimate authority have also been observed amongst
health researchers [63]. Recent scholarship on consumer
engagement describes an epistemological dissonance
amongst some researchers, where the value of under-
standing lay perspectives on health is explicitly endorsed,
but ongoing implicit privileging of expertise over experi-
ence limits meaningful incorporation of consumer
knowledge into scientific findings or related health policy
recommendations [63, 64]. This epistemological divide may
help explain why despite a strengthening consumer
movement which has amplified patient voices and informed
mental health care [28, 61, 65], consumer perspectives have
yet to exert significant influence over clinical, epidemio-
logical, social science, or health services researchers
interested in the substance use treatment gap generally, or
in estimating population need for services more specifically.
Another possibility relates to our finding that over half of
all survey research on population need for substance use
services has been conducted in the United States, where
consumer perspectives on need for services may be particu-
larly contentious. In contrast to other jurisdictions, the
Table 3 Standardized measures used to assess consumer-
defined need for substance use services (n = 217)
Variable Instrument Cited in




Stages of Change Readiness and
Treatment Eagerness Scale- Version
8 Combined [80]
[80]
Revised Risk Behaviour Assessment [81] [82]
Perceived Need for Care
Questionnaire [30]
[36, 83, 84]
National Technical Centre (NTC)
Telephone Substance Dependence
Needs Assessment Questionnaire [85]
[86]
Self-help and Treatment Services
Utilization Survey [87]
[88]
Camberwell Assessment of Need -
Forensic Short Version [89]
[90, 91]





Affordability barriers scale [93] [94–96]
Allen Barriers to Treatment
Instrument [97]
[98]
Barriers Questionnaire [99] [100]
Barriers to Treatment Instrument [101] [102]
Barriers to Treatment Inventory [103] [104]











In some cases, one or more measures, but not all measures included in the
standardized instrument where used to measure consumer-defined need.
One article measuring perceived need did not specify the name of the standardized
instrument used
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United States is home to an abundance of private,
for-profit managed behavioural health care organiza-
tions and has been embroiled in debates over state
legislation mandating parity in insurance coverage for
medical/surgical and mental health and substance use
disorders [11, 24]. Consequently, definitions of ‘need for
treatment’ are particularly contested in the United States,
and the prospect of incorporating consumer perspectives
into service planning (and thereby offering legitimacy to
public views on need for care) may raise the specter of
out-of-control costs amongst substance use service system
researchers, planners, and payers. This theory is supported
by the present analysis. In our sample, Canada, Australia,
and the United Kingdom accounted for the second, third,
and fourth largest numbers of survey research articles,
respectively; and all had higher proportions of articles
assessing consumer perspectives (24%, 19%, and 17% of
articles, respectively) than survey research conducted
in the United States (15% of articles).
Studies measuring need for services from a consumer
perspective almost always (93%; n = 201) reported one or
more expert-defined need estimates. Only a minority of
those studies (38%; n = 61) incorporated more than one
consumer-defined need measure, and only two studies
(1%) incorporated all three. Very little research in this area
was longitudinal or tested hypotheses. These findings
suggest that consumer-defined need for substance use
services may be conceptually underdeveloped, and more
often viewed as a proxy for expert-defined service need,
rather than as a construct warranting its own investigation
and analysis. Our results also suggest that extant literature
in this area has generally avoided efforts to analyze the re-
lationships between perceived need for care, self-assessed
barriers to care, and help- seeking from family and friends,
and the significance of these relationships for understanding
the substance use disorder treatment gap.
Inattention to the conceptual aspects of consumer-
defined service need may also account for the disparate
way in which perceived need for substance use services,
self-assessed barriers to service use, and help - seeking
from friends or family are measured in this literature.
Many studies used single item measures of unknown
psychometric quality. Critically, ‘services’ was inconsistently
defined. Some studies asked participants about need for, or
barriers to, generic ‘treatment,’ whereas others asked about
‘help’ instead. This is problematic because the notion of
‘treatment’ or ‘help’ may be variously interpreted by
different populations. These nonspecific measures may also
imply a particular level of intensity (e.g., residential
substance use treatment) that participants do not
perceive a need for, even if lower intensity or informal
supports might be desirable. As a result, estimates of
consumer-defined need may vary considerably across
studies and populations.
Researchers have developed a range of measurement
approaches for assessing patterns of substance use and
substance use disorders from an expert perspective. In
contrast, less than 10% of studies assessing service need
from a consumer perspective used standardized measures.
The small proportion of studies that did adopt standard-
ized measures employed several different types of instru-
ments drawn from both general mental health and
substance use literatures. Given the availability of an array
of instruments, it remains unclear why more research on
consumer-defined service need has not employed these,
or other standardized measures. Further study is required
to investigate the suitability of new and existing standard-
ized instruments for measuring consumer-defined need
for substance use services at the population level.
Methodological and measurement weaknesses demon-
strated in our review may be attributable to the disciplinary
diversity inherent in prioritizing consumer perspectives on
population need for substance use services. Research on
diagnosis and classification of mental health and substance
use disorders in the community is traditionally conducted
within the purview of psychiatric epidemiology. However,
whereas epidemiologists are concerned with understanding
prevalence, correlates, and etiological factors underlying
disease, health services researchers are primarily focused
on examining system features and other factors that pre-
dict service use [66]. Neither of these disciplinary traditions
has attended to subjective perceptions with the same
enthusiasm as psychosocial research, which focuses on
assessing individual perspectives on treatment need in
relation to psychosocial factors. Given the diversity of these
disciplinary perspectives, the present results suggest that
the concept of service need – as defined by consumers of
those services – has been neglected in extant literature.
Disciplinary diversity may also explain why so few
studies measuring perceived need have used the result-
ing data to actually estimate system capacity required to
meet population need for substance use services. We
identified only one such study in our review [57]. Unlike
health services research, epidemiological or psychosocial
research typically does not prioritize service system
planning. While it is unrealistic to expect all survey
research to directly inform system planning, it can be
argued that research measuring consumer perspectives
on service need has the implicit aim of providing
relevant data for increasing uptake into care. An
outstanding task for health services researchers is to
attempt to convert these data into required service system
capacity estimates for specific jurisdictions.
Strengths and limitations of this review
This scoping review offers a critical analysis of 35 years
of research on population need for substance use ser-
vices. It is the first review of its kind to assess the extent
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to which consumer perspectives are incorporated into
this literature, or analyze existing approaches to studying
consumer-defined need for substance use services. While
our review was comprehensive, we focused on peer-
reviewed, English literature and thus inevitably missed
studies published in other languages and possibly in the
grey literature. We also limited our scope to substance
use disorders and did not assess studies focused on
general mental health. This decision is justifiable, as
many jurisdictions plan substance use services separately
from other mental healthcare, but it limits the applic-
ability of our results to services for substance use
problems. We coded for the presence of both expert and
consumer-defined measures of need, but we did not
assess the quality of this evidence, nor characterize how
these variables were treated in each study. We also
provide no synthesis of the comprehensive empirical
findings of consumer-defined need studies in this area.
Future systematic reviews are needed to analyze whether
consumer perspectives overestimate or underestimate
population need for substance use services, how these
estimates may vary by sociodemographic and cultural
characteristics, and the relative weight that should be given
to consumer perspectives vis-a-vis objective perspectives
in treatment system capacity estimates. EH conducted the
full-text screen of all included articles independently,
which may have introduced some bias. We attempted to
mitigate this bias by ensuring other authors were consulted
and a consensus was reached for ambiguous cases.
Conclusion
A large volume of research over the past 35 years has
addressed population need for substance use services,
and scholarship in this area has grown exponentially
over the past decade. In the US and elsewhere, there has
been a growing receptivity to consumer voices in mental
healthcare practice and policymaking, enabling con-
sumers to play a larger role in their own treatment
decisions and to advocate collectively to improve ser-
vices [28]. Yet despite growth in research on population
need for substance use services, and mainstreaming of
consumer perspectives in some aspects of mental health-
care, research in this area generally downplays consumer
perspectives, both in quantifying population need for
services, and in actual service system planning. This
knowledge gap challenges our ability to predict service
utilization and improve uptake into substance use
services. Meaningful incorporation of consumer perspec-
tives into research on population need for substance use
services is overdue, and we have identified several ways
to address this task. Concerted interdisciplinary research
efforts are needed to refine the concept of consumer-
defined need, examine relationships between its con-
stituent constructs, and psychometrically validate and
standardize new or adapted measurement instruments.
Future health services research should also evaluate
approaches for incorporating consumer-defined need
measures to enhance estimates of required service sys-
tem capacity. In the absence of these efforts, the poten-
tial for consumer-defined measures of need to provide
further insight into the substance use disorder treatment
gap, and mitigate morbidity and mortality of substance
misuse, will remain unrealized.
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